| The myocardial protection of polarizing cardioplegia combined with delta-opioid receptor agonist in Swine. | |
| | |
MedLine Citation:
|
PMID: 21619990 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
BACKGROUND: The purpose of this study was to determine whether polarized arrest using adenosine/lidocaine cold crystalloid cardioplegia in combination with the hibernation inductor δ-opioid receptor agonist pentazocine would give satisfactory myocardial protection rather than using depolarized supranormal potassium cardioplegia, supranormal potassium cardioplegia with pentazocine, or adenosine/lidocaine cardioplegia. METHODS: Twenty pigs were randomly divided into four groups (n = 5 each) to receive the four types of cold crystalloid cardioplegia with an aortic cross-clamp time of 1 hour. Hemodynamic data were continuously measured, as was the left ventricular end-diastolic pressure (LVEDP), left ventricular end-systolic pressure (LVESP), plus or minus derivative of change in diastolic pressure over time (±dp/dt), cardiac output, pulmonary artery pressure, pulmonary capillary wedge pressure, cardiac troponin I, and left ventricular ultrastructure. RESULTS: Both the adenosine/lidocaine/pentazocine group and the adenosine/lidocaine group got significantly better results than the hyperkalemic and hyperkalemic pentazocine groups in improving hemodynamic values, pulmonary capillary wedge pressure, LVEDP, LVESP, ±dp/dt, cardiac output, cardiac troponin I values, and left ventricular ultrastructure. There were no statistical differences between the adenosine/lidocaine/pentazocine group and the adenosine/lidocaine group at 1 hour after cross-clamp removal; but at 2 hours after cross-clamp removal, the adenosine/lidocaine/pentazocine group stands out (LVEDP 3.3 ± 0.5, LVESP 122.5 ± 18.9, +dp/dt 2.9 ± 0.1, -dp/dt 2.0 ± 0.6, cardiac output 2.6 ± 0.4, and troponin I 4.9 ± 0.5), with significant differences from the adenosine/lidocaine group (LVEDP 5.8 ± 1.0, LVESP 98.5 ± 10.1, +dp/dt 2.5 ± 0.2, -dp/dt 1.0 ± 0.2, cardiac output 2.2 ± 0.2, troponin I 8.2 ± 0.8; p < 0.05). The defibrillation rate was largely decreased after the cross-clamp was released in the group containing pentazocine in cardioplegia. CONCLUSIONS: Adenosine/lidocaine/pentazocine cold crystalloid cardioplegia gave satisfactory cardiac arrest and better myocardial protection than the other three groups, especially with regard to improving prolonged postoperative cardiac function. |
| | |
Authors:
|
Ting Wu; Peiqing Dong; Changcheng Chen; Jing Yang; Xiaotong Hou |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Annals of thoracic surgery Volume: 91 ISSN: 1552-6259 ISO Abbreviation: Ann. Thorac. Surg. Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-05-30 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 15030100R Medline TA: Ann Thorac Surg Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 1914-20 Citation Subset: AIM; IM |
Copyright Information:
|
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved. |
Affiliation:
|
Department of Cardiopulmonary Bypass, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: ?B-Crystallin Improves Murine Cardiac Function and Attenuates Apoptosis in Human Endothelial Cells E...
Next Document: Hybrid video-assisted thoracic surgery-robotic minimally invasive right upper lobe sleeve lobectomy.